Diabetes and Immune Checkpoint Inhibitors-Response

被引：0
|
作者：
Cortellini, Alessio [1 ,2 ,4 ]
D'Alessio, Antonio [2 ,3 ]
Pinato, David J. [2 ,3 ]
机构：
[1] Fdn Policlin Univ Campus Biomed, Operat Res Unit Med Oncol, Via Alvaro Portillo, Rome, Italy
[2] Imperial Coll London, Dept Surg & Canc, Hammersmith Hosp Campus, London, England
[3] Univ Piemonte Orientale, Dept Translat Med, Div Oncol, Novara, Italy
[4] Univ Aquila, London W120HS, England
来源：
CLINICAL CANCER RESEARCH | 2023年 / 29卷 / 19期
基金：
英国惠康基金;
关键词：
D O I：
10.1158/1078-0432.CCR-23-2097
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4017 / 4018
页数：2
相关论文
共 50 条
  • [1] Immune checkpoint inhibitors and diabetes
    Campbell, Nicola
    Poole, Ruth
    [J]. PRACTICAL DIABETES, 2020, 37 (03) : 96 - 100
  • [2] Diabetes Induced by Immune Checkpoint Inhibitors (ICIs)
    Verges, Bruno
    [J]. ANNALES D ENDOCRINOLOGIE, 2023, 84 (03) : 351 - 351
  • [3] Diabetes and Immune Checkpoint Inhibitors-Letter
    Yendamuri, Sai
    Patnaik, Santosh
    [J]. CLINICAL CANCER RESEARCH, 2023, 29 (19) : 4016 - 4016
  • [4] Immune checkpoint inhibitors and diabetes: Mechanisms and predictors
    Youssef, Natalie
    Noureldein, Mohamed
    Daoud, Georges
    Eid, Assaad A.
    [J]. DIABETES & METABOLISM, 2021, 47 (03)
  • [5] Diabetes mellitus induced by immune checkpoint inhibitors
    Zheng, Zhenjiang
    Liu, Ya
    Yang, Jie
    Tan, Chunlu
    Zhou, Li
    Wang, Xing
    Xiao, Li
    Zhang, Shu
    Chen, Yonghua
    Liu, Xubao
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2021, 37 (01)
  • [6] Predictive biomarkers of response to immune checkpoint inhibitors
    Sacramento Diaz-Carrasco, Maria
    Gonzalez-Haba, Eva
    Ines Garcia-Soler, Juana
    Espuny-Miro, Alberto
    [J]. FARMACIA HOSPITALARIA, 2020, 44 (04) : 141 - 148
  • [7] Predictive biomarkers of response to immune checkpoint inhibitors
    Frelau, Alexandra
    Pracht, Marc
    Le Sourd, Samuel
    Lespagnol, Alexandra
    Corre, Romain
    Menard, Cedric
    Tarte, Karin
    Mosser, Jean
    Edeline, Julien
    [J]. BULLETIN DU CANCER, 2018, 105 : S80 - S91
  • [8] Understanding Suboptimal Response to Immune Checkpoint Inhibitors
    Zhu, Mojun
    Zhang, Henan
    Pedersen, Katrina S.
    Foster, Nathan R.
    Jaszewski, Brandy L.
    Liu, Xin
    Hirdler, Jacob B.
    An, Zesheng
    Bekaii-Saab, Tanios S.
    Halfdanarson, Thorvardur R.
    Boland, Patrick M.
    Yan, Yiyi
    Hubbard, Joleen H.
    Ma, Wen Wee
    Yoon, Harry H.
    Revzin, Alexander
    Fernandez-Zapico, Martin E.
    Overman, Michael J.
    McWilliams, Robert R.
    Dong, Haidong
    [J]. ADVANCED BIOLOGY, 2023, 7 (04):
  • [9] Biomarkers of therapeutic response with immune checkpoint inhibitors
    Bindal, Poorva
    Gray, Jhanelle E.
    Boyle, Theresa A.
    Florou, Vaia
    Puri, Sonam
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (12)
  • [10] Immune Checkpoint Inhibitors and Risk of Type 1 Diabetes
    Chen, Xuan
    Affinati, Alison H.
    Lee, Yungchun
    Turcu, Adina F.
    Henry, Norah Lynn
    Schiopu, Elena
    Qin, Angel
    Othus, Megan
    Clauw, Dan
    Ramnath, Nithya
    Zhao, Lili
    [J]. DIABETES CARE, 2022, 45 (05) : 1170 - 1176
12345